Al Mawarid Pharma has recently signed an Exclusive Distribution Contract with Pharmacare Europe Ltd – UK for the MENA region.
Al Mawarid Pharma proudly annouces that an exclusive distribution contract has been signed with Pharmacare Europe ltd – UK to Market, Promote, distribute and sell their Patent, Unique & Clinically proven food supplement & Herbal product range named (MENOFLAVON) in the territories of Jordan, Saudi Arabia, Kuwait, Qatar, Oman, Bahrain, Iraq, Algeria, Tunisia, UAE, Sudan, Morocco, Syria, Lebanon, Yemen, Libya, Egypt & Palestine (West Bank and Gaza).
the products brand names are (menoflavon & menoflavon osteo), which are considered and recognised by the 11th world congress of Menopause to be the best alternative to HRT in the treatment of menopausal and postmenopausal symptoms in Women.
Al Mawarid Pharma look forward to establish the brand name of Menoflavon and Pharmacare europe ltd in the MENA region countries.
